GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Stock Based Compensation

Bausch Health (TSX:BHC) Stock Based Compensation : C$178 Mil (TTM As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Stock Based Compensation?

Bausch Health's Stock Based Compensation for the three months ended in Dec. 2023 was C$39 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was C$178 Mil.


Bausch Health Stock Based Compensation Historical Data

The historical data trend for Bausch Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Stock Based Compensation Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 134.32 134.49 163.84 171.17 177.09

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.55 56.10 43.84 39.24 38.91

Bausch Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$178 Mil.


Bausch Health Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bausch Health's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (TSX:BHC) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (TSX:BHC) Headlines

From GuruFocus